Algeria vs Israel: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Algeria
92.0%
in 2025
Israel
92.0%
in 2025
Algeria rank
56th
Israel rank
56th
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Algeria
- Israel
How they compare
Algeria currently reports 92.0% against 92.0% in Israel, a difference of 0.0%.
The two have swapped places 7 times across 26 shared years of data; in 2000 it was Algeria ahead.
Algeria ranks 56th and Israel ranks 56th of 194 countries.
Across the 3 decades both report, Algeria averaged higher in 1 and Israel in 2.
Head to head by decade
| Decade | Algeria | Israel | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 91.5% | 85.3% | 6.2% | Algeria |
| 2010s | 91.8% | 94.4% | 2.6% | Israel |
| 2020s | 82.2% | 92.8% | 10.7% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Algeria or Israel?
- Algeria, at 92.0% against 92.0% in Israel as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Algeria and Israel?
- 0.0%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Israel?
- 26 years are reported by both, from 2000 to 2025.
- How do Algeria and Israel rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Algeria ranks 56th and Israel ranks 56th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.